buprenorphine
P05094
Approved small_molecule completed
Quick answer
buprenorphine for Opiate-related Disorders is a Approved program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Opiate-related Disorders
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed